Joint consensus highlights the role of bone turnover markers in osteoporosis diagnosis and management
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jul-2025 12:11 ET (23-Jul-2025 16:11 GMT/UTC)
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis Foundation (IOF), and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the diagnosis and management of osteoporosis. The paper reassesses the clinical utility of BTMs in predicting fracture risk and monitoring osteoporosis treatment based on evidence from the past decade. The study reaffirms the use of procollagen type I N propeptide (PINP) and β-isomerized C-terminal telopeptide of type I collagen (β-CTX-I) as reference BTMs, with standardized measurement protocols for clinical studies and patient monitoring.
The new test for silicosis has shown promise in an early study, and is now being analysed in larger cohorts.
Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman School of Public Health. Previous research has observed that past-month cannabis use has more than tripled among pregnant women in the U.S. from 2002-2020 with self-reported cannabis use rising from 1.5 percent to 5.4 percent over the 18 years of tracking data.
This cross-sectional study, spanning from December 2020 to December 2021, delves into the prevalence and risk factors of carotid artery stenosis and plaque across China. Involving 194,878 adults aged 40 and above from 31 provinces, the research leverages data from the China Stroke High-risk Population Screening and Intervention Program (CSHPSIP), adhering to the STROBE reporting guideline. The study's objective is to address the knowledge gap regarding these conditions' prevalence and associated risk factors, which previous studies have inconsistently reported.
The protective effects of Lepidium draba L. on cyclophosphamide-induced hepatotoxicity and nephrotoxicity are explored in rats.